Precipio, Inc.
NASDAQPRPO dropped its Q1 2026 results after the close on May 14, delivering a revenue beat alongside a deeper-than-year-ago loss — the kind of split verdict that leaves investors doing the math on growth versus profitability. Revenue came in at $6.71M, up 36% from $4.93M in Q1 2025. That is a meaningful acceleration for a micro-cap diagnostics company. But the earnings per share loss…
Snapshot as of 15 May 2026
PRPO dropped its Q1 2026 results after the close on May 14, delivering a revenue beat alongside a deeper-than-year-ago loss — the kind of split verdict that leaves investors doing the math on growth versus…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PRPO — free to start on ORTEX.
Sign up for free →Open PRPO on ORTEX